SO
NAUT icon

STRS Ohio’s Nautilus Biotechnolgy NAUT Stock Holding History

STRS Ohio’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,400
Closed -$8.95K – 2271
2025
Q1 		$8.95K Hold
10,400
– – ﹤0.01% 1885
2024
Q4 		$17.5K Hold
10,400
– – ﹤0.01% 1820
2024
Q3 		$29.6K Hold
10,400
– – ﹤0.01% 1868
2024
Q2 		$24.3K Hold
10,400
– – ﹤0.01% 1882
2024
Q1 		$30K Sell
10,400
-700
-6% -$1.99K ﹤0.01% 1818
2023
Q4 		$33K Hold
11,100
– – ﹤0.01% 1816
2023
Q3 		$35K Hold
11,100
– – ﹤0.01% 1835
2023
Q2 		$42K Hold
11,100
– – ﹤0.01% 1827
2023
Q1 		$30K Hold
11,100
– – ﹤0.01% 1836
2022
Q4 		$19K Hold
11,100
– – ﹤0.01% 1888
2022
Q3 		$23K Hold
11,100
– – ﹤0.01% 1915
2022
Q2 		$29K Buy
+11,100
New +$41.3K ﹤0.01% 1928

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

STRS Ohio's NAUT Position: Q2 2025 in Review

STRS Ohio sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 10,400 shares — an estimated $8.95K sold.

STRS Ohio first reported a position in NAUT in Q2 2022 and held it in 12 quarters. The position peaked at $42K in Q2 2023. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • STRS Ohio reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • STRS Ohio sold 10,400 Nautilus Biotechnolgy shares in Q2 2025, an estimated $8.95K.
  • STRS Ohio first reported a position in Nautilus Biotechnolgy in Q2 2022 and held it in 12 quarters.
  • STRS Ohio's Nautilus Biotechnolgy position peaked at $42K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.